Unbound MEDLINE

[Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)] Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti [Ceska Slov Farm] Journal article

 
Title[Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)]
Author(s)Bartosíková L, Necas J, Bartosík T, Pavlík M, Fránová J 
InstitutionUniverzita Palackého v Olomouci, Lékarská fakulta, Ustav fyziologie, Olomouc. bartosil@tunw.upol.cz
SourceCeska Slov Farm 2008 Apr; 57(2):99-102.
AbstractAllergen immunotherapy consists in the administration of the appropriate allergen to which the patient is hypersensitive. The objective is to induce immunological tolerance of the organism. In the present study, the effect of the administration of Phostal on the occurrence of seasonal symptoms of pollinosis in a group of 35 outpatients was observed during two years. The substance was administered according to the regular dosage schedule, all year round. The results of the study have demonstrated a significant effect of the product on the decrease in the occurrence of observed objective symptoms of the disease, starting already from the first year of treatment. This is in correlation with changes in the spirometric functions, selected laboratory parameters and results of the prick tests in the treated group in comparison to the control group.
Languagecze
Pub Type(s)English Abstract
Journal Article
PubMed ID18578420
  
Advertise on this site.